MDAI Key Statistics, Chart & Performance
The current stock price of MDAI is 1.61 USD. In the past month the price decreased by -23.33%. In the past year, price decreased by -16.15%.
MDAI Latest News, Press Relases and Analysis
MDAI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.83 | 224.14B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.61 | 203.30B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.43 | 150.59B | ||
| SYK | STRYKER CORP | 28.18 | 141.95B | ||
| IDXX | IDEXX LABORATORIES INC | 59.7 | 60.12B | ||
| BDX | BECTON DICKINSON AND CO | 13.45 | 55.61B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.72 | 50.29B | ||
| RMD | RESMED INC | 25.84 | 37.34B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.43 | 36.44B | ||
| DXCM | DEXCOM INC | 34.12 | 24.75B | ||
| PODD | INSULET CORP | 71.6 | 23.02B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 12.05 | 19.33B |
Related stock screener links
About MDAI
Company Profile
Spectral AI, Inc. is a predictive artificial intelligence company. The company is headquartered in Dallas, Texas and currently employs 78 full-time employees. The company went IPO on 2021-02-12. The firm's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. The company is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.
Company Info
SPECTRAL AI INC
2515 McKinney Avenue, Suite 1000
Dallas TEXAS US
Employees: 78
Phone: 12124923000
SPECTRAL AI INC / MDAI FAQ
Can you describe the business of SPECTRAL AI INC?
Spectral AI, Inc. is a predictive artificial intelligence company. The company is headquartered in Dallas, Texas and currently employs 78 full-time employees. The company went IPO on 2021-02-12. The firm's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. The company is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.
What is the stock price of SPECTRAL AI INC today?
The current stock price of MDAI is 1.61 USD. The price increased by 1.26% in the last trading session.
What is the dividend status of SPECTRAL AI INC?
MDAI does not pay a dividend.
What is the ChartMill rating of SPECTRAL AI INC stock?
MDAI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the GICS sector and industry of MDAI stock?
SPECTRAL AI INC (MDAI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the expected growth for MDAI stock?
The Revenue of SPECTRAL AI INC (MDAI) is expected to decline by -24.9% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the employee count for MDAI stock?
SPECTRAL AI INC (MDAI) currently has 78 employees.
MDAI Technical Analysis
MDAI Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to MDAI. Both the profitability and financial health of MDAI have multiple concerns.
MDAI Financial Highlights
Over the last trailing twelve months MDAI reported a non-GAAP Earnings per Share(EPS) of -0.74. The EPS decreased by -13.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -89.41% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
MDAI Forecast & Estimates
9 analysts have analysed MDAI and the average price target is 5.47 USD. This implies a price increase of 239.74% is expected in the next year compared to the current price of 1.61.
For the next year, analysts expect an EPS growth of 53.25% and a revenue growth -24.9% for MDAI